您当前的位置：

Mycro 3

目录号: PL01111 纯度: ≥99%

Mycro 3 是一种具有口服活性的、有效的选择性 Myc-Max 二聚化抑制剂。Mycro 3 可用于胰腺癌的研究。

CAS No. :944547-46-0

商品编号	规格	价格	会员价
PL01111-2mg	2mg	¥1928.00	请登录
PL01111-5mg	5mg	¥888.00	请登录
PL01111-10mg	10mg	¥1465.00	请登录
PL01111-25mg	25mg	¥2505.00	请登录
PL01111-50mg	50mg	¥3575.00	请登录
PL01111-100mg	100mg	¥4955.00	请登录
PL01111-10mM*1mLinDMSO	10mM*1mLinDMSO	¥3352.00	请登录
PL01111-1 mL x 10 mM (in DMSO)		¥1025.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!

加入购物车在线咨询收藏产品大包装询价

中文名称	Mycro 3
中文别名	Mycro 3
英文名称	Mycro 3
英文别名	5-[[[7-(Chlorodifluoromethyl)-5-(2-furanyl)pyrazolo[1,5-a]pyrimidin-2-yl]carbonyl]amino]-1-phenyl-1H-pyrazole-4-carboxylic acid ethyl ester;Mycro 3;Mycro3;Mycro-3;Mycro3; Mycro 3;C24H17ClF2N6O4;AOB6220;SYN5206;BCP32791;STK679353;ethyl 5-[[7-[chloro(difluoro)methyl]-5-(furan-2-yl)pyrazolo[1,5-a]pyrimidine-2-carbonyl]amino]-1-phenylpyrazole-4-carboxylate;ST077824;Ethyl 5-[[[7-(chlorodifluoromethyl)-5-(2-furanyl)pyrazolo[1,5-a]pyrimidin-2-yl]carbonyl]amino]-1-phenyl-1H-pyrazole-4-carboxylate (ACI)
Cas No.	944547-46-0
分子式	C₂₄H₁₇ClF₂N₆O₄
分子量	526.88
包装储存	Powder -20°C 3 years；4°C 2 years
详情描述	Mycro 3 是一种具有口服活性的、有效的选择性 Myc-Max 二聚化抑制剂。Mycro 3 可用于胰腺癌的研究。

产品详情	Mycro 3 是一种具有口服活性的、有效的选择性 Myc-Max 二聚化抑制剂。Mycro 3 可用于胰腺癌的研究。
生物活性	Mycro 3 is an orally active, potent and selective inhibitor of Myc-associated factor X (MAX) dimerization. Mycro 3 also inhibit DNA binding of c-Myc. Mycro 3 could be used for the research of pancreatic cancer.
性状	Solid
IC50 & Target[1][2]	Myc-MAX dimerization
体外研究(In Vitro)	Mycro 3 is a potent and selective c-Myc inhibitor in whole cell assays, with weak inhibitory activity against Activator protein 1 (AP-1). Mycro 3 has a superior specificity profile to its predecessors. Mycro 3 inhibits the interaction between c-Myc and Max. Mycro 3 has high selectivity and inhibits c-Myc/Max dimerization and conjugation with DNA. Mycro 3 exhibits an excellent specificity with IC50s of 0.25 and 9.0 μM for cells with intact Myc alleles and Myc-null cells, respectively. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)	Mycro 3 (100 mg/kg; oral administration; daily for two months) induces marked shrinkage of pancreatic ductal adenocarcinoma (PDA), increases cancer cell apoptosis, and reduces cell proliferation. Tumor growth is also drastically attenuated in Mycro 3-treated NOD/SCID mice carrying orthotopic or heterotopic xenografts of human pancreatic cancer cells. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. Chen BJ, et al. Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int J Biol Sci. 2014 Sep 13;10(10):1084-96. [2]. Dimitris Stellas, et al. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer. J Natl Cancer Inst. 2014 Oct 11;106(12):dju320.

溶解度数据	In Vitro: DMSO : ≥ 100 mg/mL (189.80 mM)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

[1]. Chen BJ, et al. Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int J Biol Sci. 2014 Sep 13;10(10):1084-96.
[2]. Dimitris Stellas, et al. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer. J Natl Cancer Inst. 2014 Oct 11;106(12):dju320.

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

Mycro 3

相关产品

The molarity calculator equation

The dilution calculator equation